GlobeNewswire
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
📊
AI Sentiment
Positive
7/10
- Home
- BVS
BVS
Bioventus Inc.
as of 11-28-2025 12:35pm EST
$7.55
$0.10
-1.31%
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Chart Type:
Time Range:
| Founded: | 2011 | Country: | United States |
| Employees: | 950 | City: | DURHAM |
| Market Cap: | 508.4M | IPO Year: | 2021 |
| Target Price: | $13.33 | AVG Volume (30 days): | 402.9K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.81 - $12.53 | Next Earning Date: | 11-04-2025 |
| Revenue: | $563,829,000 | Revenue Growth: | 1.58% |
| Revenue Growth (this year): | -0.15% | Revenue Growth (next year): | 7.22% |
AI-Powered BVS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 72.79%
72.79%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Bioventus Inc. (BVS)
McMurry-Heath Michelle
Sell
Director
BVS Nov 7, 2025
Avg Cost/Share
$7.42
Shares
17,701
Total Value
$131,254.69
Owned After
56,997
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| McMurry-Heath Michelle | BVS | Director | Nov 7, 2025 | Sell | $7.42 | 17,701 | $131,254.69 | 56,997 |
Latest Bioventus Inc. News
BVS Breaking Stock News: Dive into BVS Ticker-Specific Updates for Smart Investing
Compare BVS vs Leading Stocks
See how BVS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BVS Bioventus Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.